PatientsVille.com Logo

PatientsVille

Olmetec Side Effects

Common Olmetec Side Effects


The most commonly reported Olmetec side effects (click to view or check a box to report):

Diarrhoea (46)
Renal Failure Acute (41)
Dizziness (37)
Blood Pressure Decreased (35)
Blood Pressure Increased (34)
Loss Of Consciousness (31)
Hyperkalaemia (31)
Dehydration (29)
Hypotension (28)
Malaise (26)
Vomiting (26)
Headache (24)
Condition Aggravated (24)
Fall (23)
Hepatic Function Abnormal (23)
Nausea (23)
Hypoglycaemia (21)
Weight Decreased (20)
Hyponatraemia (19)
Bradycardia (19)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Olmetec Side Effects Reported to FDA

The following Olmetec reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Olmetec on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Red Blood Cell Count Decreased, Blood Lactate Dehydrogenase Increased, Haemoglobin Decreased, Haematocrit Decreased, Pneumonia
This is a report of a 65-year-old male patient (weight: NA) from JP, suffering from the following symptoms/conditions: hypertension, who was treated with Olmetec (dosage: 20 Mg, 2x/day, start time: Jan 05, 2014), combined with:
  • Amlodin (10 Mg, Unk)
  • Artist (10 Mg, Daily)
  • Cravit (500 Mg, Daily)
  • Ursodeoxycholic Acid (Unk)
  • Rebamipide (Unk)
  • Zosyn (Unk)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Red Blood Cell Count Decreased
  • Blood Lactate Dehydrogenase Increased
  • Haemoglobin Decreased
  • Haematocrit Decreased
  • Pneumonia
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Olmetec treatment in male patients, resulting in red blood cell count decreased side effect.

Diarrhoea, Gastrointestinal Disorder, Renal Failure Acute, Weight Decreased, Vomiting, Abdominal Pain Upper, Hypotension, Rectal Haemorrhage, Gastritis
This report suggests a potential Olmetec Diarrhoea, Gastrointestinal Disorder, Renal Failure Acute, Weight Decreased, Vomiting, Abdominal Pain Upper, Hypotension, Rectal Haemorrhage, Gastritis side effect(s) that can have serious consequences. A 54-year-old male patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: hypertension and used Olmetec (dosage: 40 Mg (40 Mg, 1 In 1 D), Oral) starting NS. Soon after starting Olmetec the patient began experiencing various side effects, including:
  • Diarrhoea
  • Gastrointestinal Disorder
  • Renal Failure Acute
  • Weight Decreased
  • Vomiting
  • Abdominal Pain Upper
  • Hypotension
  • Rectal Haemorrhage
  • Gastritis
Drugs used concurrently:
  • Detensiel (bisoprolol) (10 Milligram, Tablet) (bisoprolol)
  • Amlor (amlodipine Besilate) (10 Milligram, Capsule) (amlodipine Besilate)
The patient was hospitalized. Although Olmetec demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as diarrhoea, may still occur.

Fluid Retention, Local Swelling, Fall, Spinal Disorder, Headache, Knee Arthroplasty, Extra Dose Administered
This Fluid Retention, Local Swelling, Fall, Spinal Disorder, Headache, Knee Arthroplasty, Extra Dose Administered problem was reported by a consumer or non-health professional from CO. A 65-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: hypertension. On 2011 this consumer started treatment with Olmetec (dosage: NA). The following drugs were being taken at the same time:
  • Sodium Alginate/sodium Bicarbonate (sodium Bicarbonate, Sodium Alginate)(sodium Bicarbonate, Sodium
  • Ranitidine (ranitidine) (ranitidine)
When commencing Olmetec, the patient experienced the following unwanted symptoms/side effects:
  • Fluid Retention
  • Local Swelling
  • Fall
  • Spinal Disorder
  • Headache
  • Knee Arthroplasty
  • Extra Dose Administered
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as fluid retention, may become evident only after a product is in use by the general population.

Systemic Lupus Erythematosus, Weight Decreased
This is a report of a 55-year-old male patient (weight: NA) from FR. The patient developed the following symptoms/conditions: hypertension and was treated with Olmetec (dosage: NA) starting 201208. Concurrently used drugs:
  • Esomeprazole
  • Keppra
Soon after that, the consumer experienced the following side effects:
  • Systemic Lupus Erythematosus
  • Weight Decreased
This opens a possibility that Olmetec treatment could cause the above reactions, including systemic lupus erythematosus, and some male subjects may be more susceptible.


Glycosylated Haemoglobin Increased
A 71-year-old male patient (weight: NA) from AU with the following symptoms/conditions: NA started Olmetec treatment (dosage: NA) on NS. Soon after starting Olmetec treatment, the subject experienced various side effects, including:
  • Glycosylated Haemoglobin Increased
Concurrently used drugs:
  • Byetta (20 Mcg (10 Mcg, Bid), Subcutaneous)
  • Gliclazide (130 Mg (60 Mg Bid))
  • Keppra (120 Mg (60 Mg, Bid))
  • Metformin Hydrochloride
  • Verapamil Hydrochloride
  • Xarelto
The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Olmetec.

Vitreous Haemorrhage, Glaucoma, Hyperkalaemia
A 71-year-old male patient from JP (weight: NA) experienced symptoms, such as: hypertension,hiv infection and was treated with Olmetec (olmesartan Medoxomil) (tablet) (olmesartan Medoxomil)(dosage: NA). The treatment was initiated on Jun 15, 2011. After that a consumer reported the following side effect(s):
  • Vitreous Haemorrhage
  • Glaucoma
  • Hyperkalaemia
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Olmetec (olmesartan Medoxomil) (tablet) (olmesartan Medoxomil) efficacy:
  • Isentress
  • Intelence
  • Celsentri
  • Tambocor (flecainide Acetate) (flecainide Acetate)
  • Amlodin Od (amlodipine Besilate) (tablet) (amlodipine Besilate)
  • Alositol (allopurinol) (tablet) (allopurinol)
  • Bayaspirin (acetylsalicylic Acid) (tablet) (acetylsalicylic Acid)
  • Lasix (furosemide) (furosemide)
The patient was hospitalized.

Renal Failure
In this report, Olmetec was administered for the following condition: cardiac failure,dysuria,prophylaxis.A 81-year-old male consumer from JP (weight: NA) started Olmetec treatment (dosage: NA) on Dec 03, 2013.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Renal Failure
A possible interaction with other drugs could have contributed to this reaction:
  • Urief (4 Mg 2 In 1 D)
  • Nexium
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Olmetec treatment could be related to the listed above side effect(s).

Spinal Operation
This is a report of the following Olmetec Anlo side effect(s):
  • Spinal Operation
A 69-year-old female patient from BR (weight: NA) presented with the following condition: hypertension and received a treatment with Olmetec Anlo (dosage: NA) starting: May 21, 2013.The following concurrently used drugs could have generated interactions: NA.The patient was hospitalized.This report suggests that a Olmetec Anlo treatment could be associated with the listed above side effect(s).

Aortic Aneurysm
This Olmetec report was submitted by a 76-year-old female consumer from CO (weight: NA). The patient was diagnosed with: NA and Olmetec was administered (dosage: NA) starting: May 14, 2013. The consumer developed a set of symptoms:
  • Aortic Aneurysm
Other drugs used simultaneously: NA.The patient was hospitalized.Those unexpected symptoms could be linked to a Olmetec treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Blood Pressure Decreased, Blood Creatinine Increased, Renal Ischaemia
This is a report of a possible correlation between Olmetec (olmesartan Medoxomil) (tablet) (olmesartan Medoxomil) use and the following symptoms/side effect(s):
  • Blood Pressure Decreased
  • Blood Creatinine Increased
  • Renal Ischaemia
which could contribute to an assessment of Olmetec (olmesartan Medoxomil) (tablet) (olmesartan Medoxomil) risk profile.A 75-year-old male consumer from JP (weight: NA) was suffering from hypertension and was treated with Olmetec (olmesartan Medoxomil) (tablet) (olmesartan Medoxomil) (dosage: 1 In 1d) starting Jan 29, 2014.Other concurrent medications:
  • Pirolacton (1 In 1d)
  • Norvasc (amlodipine Besilate) (tablet) (amlodipine Besilate)
  • Nifedipine (nifedipine) (tablet) (nifedipine)
The patient was hospitalized.

Renal Disorder
A 49-year-old male patient from JP (weight: NA) presented with the following symptoms: hypertension and after a treatment with Olmetec (olmesartan Medoxomil) (tablet) (olmesartan Medoxomil) (dosage: NA) experienced the following side effect(s):
  • Renal Disorder
The treatment was started on Jan 01, 2014. Olmetec (olmesartan Medoxomil) (tablet) (olmesartan Medoxomil) was used in combination with the following drugs:
  • Plavix (clopidogrel)
  • Amlodin Od (amlodipine Besilate)
The patient was hospitalized.This report could alert potential Olmetec (olmesartan Medoxomil) (tablet) (olmesartan Medoxomil) consumers.

Red Blood Cell Count Decreased, Blood Lactate Dehydrogenase Increased, Haemoglobin Decreased, Haematocrit Decreased, Pneumonia
In this report, a 65-year-old male patient from JP (weight: NA) was affected by a possible Olmetec side effect.The patient was diagnosed with hypertension,pneumonia. After a treatment with Olmetec (dosage: 40mg Per Day, start date: Jan 05, 2014), the patient experienced the following side effect(s):
  • Red Blood Cell Count Decreased
  • Blood Lactate Dehydrogenase Increased
  • Haemoglobin Decreased
  • Haematocrit Decreased
  • Pneumonia
The following simultaneously used drugs could have led to this reaction:
  • Cravit (500mg Per Day)
  • Artist (10mg Per Day)
  • Amlodipine
  • Zosyn
  • Ursodeoxycholic Acid
  • Rebamipide
The findings here stress that side effects should be taken into consideration when evaluating a Olmetec treatment.

Nephrolithiasis, Bacterial Infection, Medical Device Complication
This is a report of a 57-year-old male patient from CO (weight: NA), who used Olmetec (olmesartan Medoxomil) (tablet) (olmesartan Medoxomil) (dosage: NA) for a treatment of hypertension. After starting a treatment on NS, the patient experienced the following side effect(s):
  • Nephrolithiasis
  • Bacterial Infection
  • Medical Device Complication
The following drugs could possibly have interacted with the Olmetec (olmesartan Medoxomil) (tablet) (olmesartan Medoxomil) treatment NA.Taken together, these observations suggest that a Olmetec (olmesartan Medoxomil) (tablet) (olmesartan Medoxomil) treatment could be related to side effect(s), such as Nephrolithiasis, Bacterial Infection, Medical Device Complication.

Renal Failure Acute, Hyperkalaemia, Fatigue, Malaise, Fall
This renal failure acute side effect was reported by a consumer or non-health professional from BE. A 61-year-old male patient (weight:NA) experienced the following symptoms/conditions: hypertension,oedema peripheral. The patient was prescribed Olmetec (dosage: NA), which was started on 2011. Concurrently used drugs:
  • Moxon (mononidine) (0.4 Milligram, Tablet) (mononidine)
  • Metformax (metformin Hydrochloride) (850 Milligram, Tablet) (metformin Hydrochloride)
  • Novorapid (insulin Aspart) (injection) (insulin Aspart)
  • Lantus (insulin Glargine) (insulin Glargine)
  • Inegy (simvastatin, Ezetimibe) (tablet) (simvastatin, Ezetimibe)
  • Elthyrone (levothyroxine Sodium) (300 Milligram, Tablet) (levothyroxine Sodium)
  • Lyrica (pregablin) (300 Milligram, Capsule) (pregabalin)
When starting to take Olmetec the consumer reported the following symptoms:
  • Renal Failure Acute
  • Hyperkalaemia
  • Fatigue
  • Malaise
  • Fall
The patient was hospitalized. These side effects may potentially be related to Olmetec.

Abdominal Discomfort, Constipation, Dizziness, Dyspepsia, Flatulence, Headache, Nausea, Product Substitution Issue
This is a Olmetec (olmesartan Medoxomil) (20 Milligram, Tablet) (olmesartan Medoxomil) side effect report of a 84-year-old female patient (weight:NA) from CA, suffering from the following symptoms/conditions: NA, who was treated with Olmetec (olmesartan Medoxomil) (20 Milligram, Tablet) (olmesartan Medoxomil) (dosage:NA, start time: NS), combined with:
  • Losartan
, and developed a serious reaction and a abdominal discomfort side effect. The patient presented with:
  • Abdominal Discomfort
  • Constipation
  • Dizziness
  • Dyspepsia
  • Flatulence
  • Headache
  • Nausea
  • Product Substitution Issue
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Olmetec (olmesartan Medoxomil) (20 Milligram, Tablet) (olmesartan Medoxomil) treatment in female patients suffering from NA, resulting in abdominal discomfort.

Angioedema, Dysphagia, Lip Swelling, Oedema Mouth, Pharyngeal Oedema, Pruritus, Swollen Tongue, Urticaria
This report suggests a potential Olmetec (olmesartan Medoxomil) (tablet) (olmesartan Medoxomil) angioedema side effect(s) that can have serious consequences. A 64-year-old female patient from CA (weight:NA) was diagnosed with the following health condition(s): NA and used Olmetec (olmesartan Medoxomil) (tablet) (olmesartan Medoxomil) (dosage: NA) starting NS. Soon after starting Olmetec (olmesartan Medoxomil) (tablet) (olmesartan Medoxomil) the patient began experiencing various side effects, including:
  • Angioedema
  • Dysphagia
  • Lip Swelling
  • Oedema Mouth
  • Pharyngeal Oedema
  • Pruritus
  • Swollen Tongue
  • Urticaria
Drugs used concurrently:
  • Diflucan (fluconazole) (fluconazole)
  • Lorazepam (lorazepam) (lorazepam)
  • Losec (omeprazole) (omeprazole)
  • Premarin (estrogens Conjugated) (estorgens Conjugated)
  • Synthroid (levothyroxine Sodium) (levothyroxine Sodium)
Although Olmetec (olmesartan Medoxomil) (tablet) (olmesartan Medoxomil) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as angioedema, may still occur.

Condition Aggravated, Heart Rate Irregular
This condition aggravated problem was reported by a consumer or non-health professional from CA. A 53-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): NA.On NS a consumer started treatment with Olmetec (olmesartan Medoxomil) (dosage: 20 Mg (20 Mg, Qd), Per Oral). The following drugs/medications were being taken at the same time: NA. When commencing Olmetec (olmesartan Medoxomil), the patient experienced the following unwanted symptoms /side effects:
  • Condition Aggravated
  • Heart Rate Irregular
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as condition aggravated, may become evident only after a product is in use by the general population.

Pneumonia Aspiration
This is a Olmetec side effect report of a 89-year-old female patient (weight: NA) from JP. The patient developed the following symptoms/conditions: hypertension,cardiac failure chronic and was treated with Olmetec (dosage: NA) starting NS. Concurrently used drugs:
  • Artist
  • Amlodipine (amlodipine) (amlodipine)
Soon after that, the consumer experienced the following of symptoms:
  • Pneumonia Aspiration
The patient was hospitalized. This opens a possibility that Olmetec could cause pneumonia aspiration and that some female patients may be more susceptible.

Blood Urea Increased, Blood Creatinine Increased, Toxicity To Various Agents, Dizziness, Renal Impairment
A 56-year-old female patient (weight: NA) from JP with the following symptoms: hypertension started Olmetec treatment (dosage: 20 Mg (20 Mg, 1 In 1 D), Per Oral) on NS. Soon after starting Olmetec treatment, the consumer experienced several side effects, including:
  • Blood Urea Increased
  • Blood Creatinine Increased
  • Toxicity To Various Agents
  • Dizziness
  • Renal Impairment
. Concurrently used drugs:
  • Limas (lithium Carbonate)
  • Lamictal (lamotrigine)
  • Nitrazepam (nitrazempam)
  • Seroquel (quetiapine Fumarate)
  • Alosenn (senna Alexandrina)
  • Bisacodyl (bisacodyl)
The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Olmetec side effects, such as blood urea increased.

Hepatitis Fulminant, Depressed Level Of Consciousness, Prothrombin Time Shortened, Blood Pressure Abnormal
This hepatitis fulminant side effect was reported by a consumer or non-health professional from JP. A 79-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Olmetec (dosage: NA), which was started on NS. Concurrently used drugs:
  • Mevalotin
  • Loxonin (When Painful)
  • Famotidine
  • Sofalcone
  • Sevevacul (sennoside A+b) ( Tablet) (sennoside
.When starting to take Olmetec the consumer reported symptoms, such as:
  • Hepatitis Fulminant
  • Depressed Level Of Consciousness
  • Prothrombin Time Shortened
  • Blood Pressure Abnormal
These side effects may potentially be related to Olmetec.

Mammoplasty, Hypotension
This is a report of a 63-year-old female patient (weight: NA) from BR, suffering from the following symptoms/conditions: hypertension, who was treated with Olmetec Hct (dosage: NA, start time: 2010), combined with:
  • Vitamins (vitamins Nos) (vitamins Nos)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Mammoplasty
  • Hypotension
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Olmetec Hct treatment in female patients, resulting in mammoplasty side effect. The patient was hospitalized.

Colitis Ulcerative
This report suggests a potential Olmetec Colitis Ulcerative side effect(s) that can have serious consequences. A 64-year-old male patient (weight: NA) from BE was diagnosed with the following symptoms/conditions: hypertension and used Olmetec (dosage: 20 Mg ( 20 Mg. 1 In 1 D), Oral) starting Oct 14, 2011. Soon after starting Olmetec the patient began experiencing various side effects, including:
  • Colitis Ulcerative
Drugs used concurrently: NA. Although Olmetec demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as colitis ulcerative, may still occur.

Cardiac Arrest, Intestinal Cyst, Colon Neoplasm
This Cardiac Arrest, Intestinal Cyst, Colon Neoplasm problem was reported by a consumer or non-health professional from CO. A 81-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: hypertension. On 201110 this consumer started treatment with Olmetec (dosage: 40 Mg (40 Mg, Qd), Per Oral). The following drugs were being taken at the same time:
  • Lipitor (40 Mg (40 Mg, Qd), Per Oral)
  • Lipitor (40 Mg (40 Mg, Qd), Per Oral)
  • Prestor
When commencing Olmetec, the patient experienced the following unwanted symptoms/side effects:
  • Cardiac Arrest
  • Intestinal Cyst
  • Colon Neoplasm
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as cardiac arrest, may become evident only after a product is in use by the general population.

Gastrointestinal Carcinoma
This is a report of a 79-year-old female patient (weight: NA) from BR. The patient developed the following symptoms/conditions: hypertension,blood cholesterol increased and was treated with Olmetec Hct (dosage: NA) starting Jun 30, 2011. Concurrently used drugs:
  • Lipitor (atorvastatin Calcium) (tablet) (atorvastatin Calcium)
Soon after that, the consumer experienced the following side effects:
  • Gastrointestinal Carcinoma
The patient was hospitalized. This opens a possibility that Olmetec Hct treatment could cause the above reactions, including gastrointestinal carcinoma, and some female subjects may be more susceptible.

Hypophagia, Weight Decreased
A 56-year-old female patient (weight: NA) from NL with the following symptoms/conditions: hypertension started Olmetec (olmesartan Medoxomil) (20 Milligram, Tablet) (olmesartan Medoxomil) treatment (dosage: NA) on Aug 04, 2013. Soon after starting Olmetec (olmesartan Medoxomil) (20 Milligram, Tablet) (olmesartan Medoxomil) treatment, the subject experienced various side effects, including:
  • Hypophagia
  • Weight Decreased
Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Olmetec (olmesartan Medoxomil) (20 Milligram, Tablet) (olmesartan Medoxomil).

1 of 31 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Olmetec Side Effects

    Did You Have a Olmetec Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Olmetec for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective